
Beyond Sugar & Fat π¬πβοΈ The GLP-1 Revolution in Diabetes, Obesity, and Beyond
Dr RR Baliga's "Got Knowledge Doc" Podkast Β· MasterMedFacts lLC
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
π Exciting breakthroughs in metabolic medicine! π This August 2025 Nature Reviews Drug Discovery review by Dr. Daniel Drucker dives deep into the evolution of GLP-1-based therapiesβcovering semaglutide, tirzepatide, multi-agonists, oral small molecules, and their growing impact beyond diabetes into obesity, liver disease, and neurodegeneration. π§ βοΈπ₯
π From gut hormones to global health, GLP-1 therapies are redefining chronic disease care.
π Read, reflect, and get ready for what's next: #GLP1 #ObesityMedicine #IncretinTherapies #PharmaInnovation #MetabolicHealth #Tirzepatide #Semaglutide #DrugDiscovery #PrecisionMedicine #Endocrinology π₯